1. Blood product transfusion practices in neonates with hypoxic-ischemic encephalopathy.
- Author
-
Miran AA, Stoopler M, Cizmeci MN, El Shahed A, Yankanah R, Danguecan A, Ly L, Signorile M, Runeckles K, Fan CS, and Kalish BT
- Subjects
- Humans, Retrospective Studies, Infant, Newborn, Male, Female, Intensive Care Units, Neonatal, Hospital Mortality, Blood Transfusion, Multivariate Analysis, Plasma, Hypothermia, Induced, Hypoxia-Ischemia, Brain therapy
- Abstract
Objective: Blood product transfusion is a common practice in infants with hypoxic-ischemic encephalopathy (HIE) undoing therapeutic hypothermia (TH). The advantages and disadvantages of conservative or liberal transfusion practices in this fragile population are unknown. Study aims to characterize the transfusion practices in infants with HIE and investigate the association with outcome., Study Design: We conducted a retrospective cohort study at a single level IV NICU, evaluating transfusion thresholds, as well as the association between hematological abnormalities or blood product transfusions and outcomes in infants admitted with HIE., Result: By univariate analysis, FFP transfusion was associated with increased in-hospital death. However, multivariate analysis adjusting for HIE severity demonstrated no association between hematological abnormality or blood product transfusion and death, nor with neurodevelopmental impairment., Conclusion: No association was found between hematological blood product transfusion and death or neurodevelopmental impairment in a retrospective single NICU study of infants with HIE., (© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.)
- Published
- 2024
- Full Text
- View/download PDF